Lockheed Martin has licensed the bionic augmentation technology Dermoskeleton™ from B-Temia, with an eye towards a new generation of industrial and military exoskeletons.
Dermoskeleton is the basis for computer-controlled devices that can increase load-carrying capacity and mobility by counteracting overstress on the lower back and legs.
Lockheed Martin’s technology license permits use of B-Temia technology to products for military, industrial, commercial and first-responder applications.
“This technology offers a pathway to increased loadbearing and greater agility for our FORTIS industrial exoskeleton,” said Glenn Kuller, Advanced and Special Programs vice president at Lockheed Martin Missiles and Fire Control.
“It can also help to solve existing limitations of powered exoskeletons for our military and first responders.”
“We’re excited about the potential we see here.”
(Trish Aelker of Lockheed Martin describes the use of the FORTIS Exoskeleton. Courtesy of National Geographic and YouTube. Posted on Nov 5, 2015)
“This agreement confirms our company’s technology leadership and value of our work in increasing human mobility in both industrial and defense applications,” said B-Temia President and CEO Stéphane Bédard.
“Our arrangement with Lockheed Martin provides another avenue for our bionic technology to enhance human performance.”
The FORTIS exoskeleton is an unpowered, lightweight exoskeleton that increases an operator’s strength and endurance by transferring the weight of heavy loads from the operator’s body directly to the ground through a series of joints at the hips, knees and ankles.
(Learn More, as Director Paul Giamatti gets a demonstration of the Fortis Exoskeleton, developed by Lockheed Martin. Courtesy of National Geographic and YouTube. Posted on Nov 5, 2015)
Originating from Lockheed Martin’s exoskeleton research to assist soldiers in carrying heavy equipment over long distances, the same principles were applied to exoskeleton development for use in industrial settings.
Founded in 2010, B-Temia is a developer and manufacturer of bionic technology in the growing market of human augmentation.
Its proprietary Dermoskeleton™ technology provides improved mobility, strength and autonomy to the user, with applications in the medical, industrial and military fields.